T32 ITOS Program Training Environment

Charleston, South Carolina

The Medical University of South Carolina (MUSC) is located in historic Charleston, South Carolina, which is known for its culture and beauty. Named the number one city in the world for five consecutive years, Charleston is known for its cobblestone streets and quintessential southern charm. The Charleston area is a vibrant, family-friendly region that boasts numerous beaches, protected wetlands, religious diversity, historic attractions, rich cultural offerings, championship golf courses, award-winning restaurants, competitive sporting events, and an incomparable quality of life.

Medical University of South Carolina

MUSC is a research-intensive institution — receiving more than $247 million in extramural research funding in FY2015, of which $79 million emanated from the NIH — and is recognized for its culture of collaborative, interdisciplinary research validated by a large portfolio of NIH-funded center grants. It is also a stimulating and well-structured environment for training junior investigators and ranks in the top quartile of domestic educational institutions in number of NIH grants for research training.

MUSC Hollings Cancer Center

MUSC Hollings Cancer Center is one of only 71 NCI-designated cancer centers in the U.S. Hollings was founded in 1993 and serves the state as a leader in cancer research, patient care, and public and professional education. Since its opening, Hollings has had significant growth in clinical and research facilities, patient care volume, research funding, and its clinical trials portfolio and accrual.

The goals of Hollings are to:

• Create an environment where cancer research will be fostered from basic concept to clinical/community intervention.
• Develop epidemiologic, environmental, and behavioral research to reduce the cancer burden and disparities in rural, underserved populations.
• Train the next generation of basic, translational, clinical, and prevention researchers.
• Lead the coordination of statewide efforts in research, education, and clinical care.

With an annual research funding portfolio of more than $44 million and more than 120 faculty cancer scientists across 20 academic departments, the highly interactive research programs of Hollings provide fertile ground for scientific interactions and mentorship. Members are organized into three formal research programs — Cancer Biology & Immunology, Cancer Control, and Developmental Cancer Therapeutics.